BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201201
DTEND;VALUE=DATE:20201203
DTSTAMP:20201127T195218Z
CREATED:20201127T195203Z
LAST-MODIFIED:20201127T195218Z
UID:48069-1606780800-1606953599@globalbiodefense.com
SUMMARY:Security of America’s Medical Product Supply Chain - Public Workshop
DESCRIPTION:The National Academies’ Committee on Security of America’s Medical Product Supply Chain will host its second meeting and a public workshop from December 1-3\, 2020. \nThe public workshop will be held on December 1 (12:00pm to 3:30pm) and December 2 (11:30am to 3:30pm). \nObjectives for the public workshop include the following: \n\nConsider on-the-ground perspectives from end users of the medical supply chain (e.g.\, patients\, clinicians\, health systems) when it comes to:\n\nwhat makes a medical product critical/essential\noutcome measures that matter to end users\napproaches to mitigate the impact of failures in the medical supply chain\n\n\nExamine current lists of “critical/essential” medical products with attention to how these lists were formulated and how they are used to inform decisions;\nDiscuss key considerations for the formulation of a unified list of critical medical products;\nConsider tactical approaches for improving supply chain resiliency.\n\nBackground\nIn response to the CARES Act\, the National Academies of Sciences\, Engineering\, and Medicine will establish an ad hoc committee to conduct a study to examine the security of the United States medical product supply chain. The committee will assess and evaluate the dependence of the United States on critical drugs and devices that are sourced or manufactured outside of the United States and provide recommendations to improve the resiliency of the medical supply chain. \nThe committee will: \n1) assess and evaluate the dependence of the United States\, including the private commercial sector\, States\, and the Federal Government\, on critical drugs and devices that are sourced or manufactured outside of the United States\, which may include an analysis of: \n\nthe supply chain of critical drugs and devices of greatest priority to providing health care;\nany potential public health security or national security risks associated with reliance on critical drugs and devices sourced or manufactured outside of the United States\, which may include responses to previous or existing shortages or public health emergencies\, such as infectious disease outbreaks\, bioterror attacks\, and other public health threats;\nany existing supply chain information gaps\, as applicable; and\npotential economic impact and other considerations associated with increased domestic manufacturing; and\n\n2) provide recommendations to improve the resiliency of the supply chain for critical drugs and devices and to address any supply vulnerabilities or potential disruptions of such products that would significantly affect or pose a threat to public health security or national security\, as appropriate\, which may include strategies to: \n\npromote supply chain redundancy and contingency planning;\nencourage domestic manufacturing\, including consideration of economic impacts\, if any;\nimprove supply chain information gaps;\nimprove planning considerations for medical product supply chain capacity during public health emergencies; and\npromote the accessibility of such drugs and devices.
URL:https://globalbiodefense.com/event/security-of-americas-medical-product-supply-chain-public-workshop/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201201T170000
DTEND;TZID=America/New_York:20201201T180000
DTSTAMP:20201127T194745Z
CREATED:20201127T194745Z
LAST-MODIFIED:20201127T194745Z
UID:48067-1606842000-1606845600@globalbiodefense.com
SUMMARY:Assessment of the SBIR and STTR Programs at NIH - Meeting 8
DESCRIPTION:The Eighth Meeting of the Committee on the Assessment of the SBIR and STTR Programs at the National Institutes of Health (NIH) will be held virtually on December 1\, 2020. \nWhat is the effectiveness of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH)? An ad hoc committee will conduct a study of the economic and healthcare benefits of the SBIR and STTR programs at NIH and the effectiveness of the enabling strategies NIH has employed to enhance the programs. \nMeeting will be held via Zoom. This meeting will be open in its entirety. \nPlease write to step@nas.edu to attend. \nBackground\nIn response to a Congressional mandate\, an ad hoc committee will conduct a study of the economic and healthcare benefits of the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs at the National Institutes of Health (NIH) and the effectiveness of the enabling strategies NIH has employed to enhance the programs. The committee will draw on published research; existing\, available data; and case studies\, and convene a series of meetings. Specifically and to the extent that data are available\, the committee will examine: \nSBIR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available to the committee\, case studies\, and other available data\, the committee will examine whether the NIH SBIR Program is fulfilling the requirements of the enabling legislation; and study the impact and effectiveness of the enabling strategies NIH has employed to enhance the program\, including\, but not limited to\, technical and business assistance programs and the Phase IIB program. \nSTTR effectiveness: Leveraging existing NIH evaluation strategies and data that are made available\, the committee will study how the NIH STTR Program\, including the strategies designed to enable academic entrepreneurship and innovation\, has fulfilled the requirements of the enabling legislation\, including: \n\nA review of the collaborations created between small businesses and research institutions\, including an evaluation of the effectiveness of the program in stimulating new collaborations and any obstacles that may prevent or inhibit the creation of such collaborations.\nAn evaluation of the effectiveness of the program at transferring federally funded technology and capabilities toward commercialization.\nAn examination of the non-economic impacts to businesses including measures of demographics\, participation of underrepresented groups\, and knowledge of the technical and business requirements of life science sector commercialization.\nAn analysis of whether STTR funds could be employed more effectively by the NIH STTR program to achieve the goals of the enabling legislation.
URL:https://globalbiodefense.com/event/assessment-of-the-sbir-and-sttr-programs-at-nih-meeting-8/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201203T110000
DTEND;TZID=America/New_York:20201203T143000
DTSTAMP:20201127T210413Z
CREATED:20201127T210413Z
LAST-MODIFIED:20201127T210413Z
UID:48071-1606993200-1607005800@globalbiodefense.com
SUMMARY:Lessons Learned in Health Professions Education from the COVID-19 Pandemic
DESCRIPTION:A planning committee of the National Academies of Sciences\, Engineering\, and Medicine will organize and conduct a 1-day public workshop on Dec. 3\, 2020 to explore lessons learned in grand challenges facing health professions education (HPE) stemming from the COVID-19 pandemic and how those positive and negative experiences might inform development of sustainable improvements in the value\, effectiveness\, and impact of HPE. The planning committee will bring together educators\, students\, administrators\, and health professionals to share ideas\, stories\, and data in an effort to discuss the future of HPE by learning from past experiences. Invited presentations and discussions will involve global audiences in topics such as: \n\nExamples and evaluation of online education;\nInnovations in interprofessional education and learning opportunities within the social determinants of health and mental health;\nImpacts on pre-clinical and clinical education;\nRegulatory and accreditation changes affecting HPE; and\nStress and workload on students and faculty.\n\nRegister here.
URL:https://globalbiodefense.com/event/lessons-learned-in-health-professions-education-from-the-covid-19-pandemic/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201207
DTEND;VALUE=DATE:20201210
DTSTAMP:20201127T212644Z
CREATED:20201127T212644Z
LAST-MODIFIED:20201127T212644Z
UID:48073-1607299200-1607558399@globalbiodefense.com
SUMMARY:DoD Materials Science and Engineering in a Post-Pandemic World: A Workshop
DESCRIPTION:How has COVID-19 affected Department of Defense materials and manufacturing capabilities\, and what does this mean for future workforce needs? The National Academies invites you to explore Materials Science and Engineering in a Post-Pandemic World as part of a three-day virtual public workshop December 7-9\, 2020. \nWorkshop topics will include 1) how COVID-19 is impacting and is expected to impact DOD materials and manufacturing capabilities; 2) how the current materials and manufacturing workforce is affected; 3) efforts being considered to address future DOD materials and manufacturing needs; and 4) the future of the DOD workforce pipeline. \nLearn more and register: https://bit.ly/dod-post-pandemic-mfc \n 
URL:https://globalbiodefense.com/event/dod-materials-science-and-engineering-in-a-post-pandemic-world-a-workshop/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201210T190000
DTEND;TZID=America/New_York:20201210T200000
DTSTAMP:20201127T215208Z
CREATED:20201127T215208Z
LAST-MODIFIED:20201127T215208Z
UID:48075-1607626800-1607630400@globalbiodefense.com
SUMMARY:Mathematics Problem Solving and Professional Development Under the COVID-19 Pandemic
DESCRIPTION:A webcast talk on “Mathematics Problem Solving and Professional Development Under the COVID-19 Pandemic” will be held December 10\, 2020 as Part 4 in the webinar series\, “Moving Forward in the Midst of a Pandemic: International Lessons for Math Teachers” Hosted by the U.S. National Commission of Mathematics Instruction – National Academies of Sciences\, Engineering\, and Medicine \nAbout the speaker:\nPatricio Felmer is a Mathematical Engineer from the University of Chile and holds a Ph.D. in Mathematics from the University of Wisconsin-Madison.  He has been Director of the Department of Mathematical Engineering (1999-2001)\, Member of the Fondecyt Higher Science Council (2002-2005)\, and is a member of the Chilean Academy of Sciences.  Dr. Felmer dedicated the first part of his academic life to mathematical research\, making numerous scientific contributions in the area of Hamiltonian systems\, partial differential equations and nonlinear analysis.  In the second part\, he has directed his interests to education\, dedicating his efforts to collaborate in the improvement of education with a country vision.  Together with collaborators\, he founded the ARPA Initiative\, a teacher professional development program\, whose purpose is to incorporate Problem Solving in Chilean classrooms\, with the goal of transforming classroom relationships.  The proposal seeks to move a classroom conducted by the teacher\, with passive students\, to one where students actively learn and the teacher orchestrate their work\, proposing stimulating activities\, and promoting autonomy and collaboration.
URL:https://globalbiodefense.com/event/mathematics-problem-solving-and-professional-development-under-the-covid-19-pandemic/
CATEGORIES:Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20201214
DTEND;VALUE=DATE:20201218
DTSTAMP:20200927T230726Z
CREATED:20200927T230726Z
LAST-MODIFIED:20200927T230726Z
UID:47223-1607904000-1608249599@globalbiodefense.com
SUMMARY:Brookhaven Laboratory Workshop for Industry Researchers
DESCRIPTION:Do you have an R&D challenge that you can’t solve with traditional commercial techniques? This specialized virtual workshop will offer access to unique x-ray\, electron and optical techniques\, which are designed for understanding materials in unprecedented ways. \nBrookhaven National Laboratory will host a virtual workshop on December 14-17\, 2020 for industry researchers to showcase the capabilities and expertise available at U.S. Department of Energy (DOE) Office of Science User Facilities located at Brookhaven Lab. \nThe workshop is designed to benefit both researchers who have previously used Brookhaven facilities for their work and those who are interested in learning about accessing them for the first time. \nThe workshop will inform researchers from industry about the leading-edge capabilities and expertise at Brookhaven facilities\, and provide details about the mechanisms for accessing them. The workshop will also more broadly introduce participants to DOE programs designed to support industry research. \nThe workshop agenda will feature presentations from industry users of Brookhaven Lab facilities\, question-and-answer sessions\, and opportunities to directly hear from Department of Energy program managers for your questions. \nHighlighted presentations include: \n\nBio and pharmaceuticals\nNanofabrication; Materials synthesis and characterization\nInnovative Chemistry through Advanced Microscopy Techniques\, Ke‐Bin Low\, BASF\nBio‐inspired invisible glass: from nature to commercialization\, Calvin Cheng\, Edgehog\nOverview of capabilities of NSLS‐II and CFN\, John Hill\, BNL\nX‐ray diffraction/scattering\nElectron microscopy\nHard and soft x‐ray spectroscopy\nAdvanced UV and x‐ray probes\nImaging and microscopy\nAdvanced optical spectroscopy and microscopy\nLessons learned as industry users of BNL facilities ‐‐ panel discussion\nDOE SBIR/STTR Program\, Manny Oliver\, SBIR/STTR Program Office\, DOE\nDOE TIR Program\, Eli Levine\, Advanced Manufacturing Office\, DOE\nDOE TCF Program\, Zack Baize\, Office of Technology Transitions\, DOE\nStrategic Partnership Program\, Ivar Strand\, BNL\nHelp desk and other DOE user facilities Q&A\nHow to become an industrial user and access facilities – Jun Wang (EPS)\nHow to write a good nonproprietary industrial proposal – Lisa Miller (NSLS‐II)\, Priscilla\nAntunez (CFN)\n\nThe workshop will provide a unique “facilities open house” format\, where attendees will spend time remotely in the labs observing Brookhaven’s capabilities in action and engaging in technical discussions with Brookhaven experts. The workshop will also provide an opportunity for attendees to remotely measure their own samples\, collecting meaningful data to take home that day. \nLearn more
URL:https://globalbiodefense.com/event/brookhaven-laboratory-workshop-for-industry-researchers/
LOCATION:Brookhaven Lab – Berkner Hall\, Lewis Road\, Upton\, 11973\, United States
CATEGORIES:Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/brookhaven-national-lab-doe-science-user-facilities-industry-researchers-event.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201215T120000
DTEND;TZID=America/New_York:20201216T170000
DTSTAMP:20201127T221649Z
CREATED:20201127T221649Z
LAST-MODIFIED:20201127T221649Z
UID:48078-1608033600-1608138000@globalbiodefense.com
SUMMARY:Ethical\, Legal\, and Regulatory Issues Associated with Neural Chimeras and Organoids
DESCRIPTION:The fourth full meeting of the Committee on Ethical\, Legal\, and Regulatory Issues Associated with Neural Chimeras and Organoids will be held online December 15-16\, 2020. \nSome sessions are open to the public and some sessions are closed. \nThis ad hoc committee of the National Academies of Sciences\, Engineering\, and Medicine will examine the scientific\, ethical and regulatory issues associated with neural chimeras and neural organoid research. \nThe committee will review the status of research\, consider the benefits and risks of such research\, discuss associated ethical issues\, and consider what oversight mechanisms might be appropriate in this area. \nThe committee will consider questions such as: \n\nHow would researchers define or identify enhanced or human awareness in a chimeric animal?\nDo research animals with enhanced capabilities require different treatment compared to typical animal models? What are appropriate disposal mechanisms for such models?\nWhat types of brain tissue are appropriate for use as neural organoids?\nHow large or complex would the ex vivo brain organoids need to be to attain enhanced or human awareness?\nWhat kind of “humanized” brain\, in size and structures\, would be acceptable in a research animal?\nShould patients give explicit consent for their cells to be used to create neural organoids?\nWhat regulatory mechanisms relating to organoid and chimeric animal research are currently in place? Are there gaps in the current regulatory framework?\nWhat regulatory mechanisms exist for similar research?\nWhat further regulatory mechanisms might be appropriate?\n\nLearn more: https://bit.ly/neuralchimerasorganoids \n 
URL:https://globalbiodefense.com/event/ethical-legal-and-regulatory-issues-associated-with-neural-chimeras-and-organoids/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
END:VCALENDAR